Resources Contact Us Home
Immunological composition of measles virus utilizing recombinant poxvirus

Image Number 18 for United States Patent #5759841.

What is described is a recombinant poxvirus, such as vaccinia virus or canarypox virus, containing foreign DNA from Morbillivirus. In one embodiment, the foreign DNA is expressed in a host by the production of a measles virus glycoprotein. In another embodiment, the foreign DNA is expressed in a host by the production of at least two measles virus glycoproteins. What is also described is a vaccine containing the recombinant poxvirus for inducing an immunological response in a host animal inoculated with the vaccine. By the present invention, cross-protection of dogs against canine distemper is obtained by inoculating the dog with the recombinant poxvirus.

  Recently Added Patents
Differentiated PSIP table update interval technology
Nutritional supplement method
Systems and methods for managing and utilizing excess corn residue
Surface emitting laser device, surface emitting laser array, optical scanning device, and image forming apparatus
Switching apparatus and controlling method thereof
Bipolar transistor with diffused layer between deep trench sidewall and collector diffused layer
Adding co-users to user definable co-user lists
  Randomly Featured Patents
Topical and transdermal treatments using urea formulation
Replacement unit and image forming device
Methods for testing and programming nanoscale electronic devices
Polycyclic chlorinated hydrocarbons containing bridgehead or imino nitrogen
Liquid crystal display with stopper pins in guide means
Selenium or tellurium elemental hydrosols and their preparation
Counterweight for construction machine
Process for the preparation of acitretin
Heteroatom-bearing ligands and metal complexes thereof
Panty hose sizing form